Back
HFA Premium Access

Prognostic impact of polypharmacy drugs across heart failure phenotypes: an unmet need.

Session: Poster Session 1 - Drug therapy, other
Topic: Drug therapy, other
Speaker: Doctor C. Di Nora (Udine, IT)
Event: HEART FAILURE 2016

Congress Presentation

Add to my library

Like

About the speaker

Doctor Concetta Di Nora

Hospital Santa Maria della Misericordia, Udine (Italy)
0 follower

8 more presentations in this session

Laboratory aspirin resistance reversibility in coronary artery disease and chronic obstructive pulmonary disease patients after coronary stent implantation

Speaker: Professor I. Pershukov (Osh, KG)

Access
Abstract
Slides
Like
Thumbnail

Temporal trends in the use of digoxin in patients heart failure

Access
Like
Thumbnail

P2Y12 inhibitors in acute coronary syndrome: relation to hemorrhagic events in routine clinical practice

Speaker: Doctor A. Godinho (Porto, PT)

Access
Abstract
Like
Thumbnail

Hyper-Kalaemia as cause for discontinuation of RAASi in patients with heart failure

Speaker: Professor G. Rosano (London, GB)

Access
Abstract
Like
Thumbnail

Analysis of changes of ECHO-cardiogram indices in patients with chronic heart failure during therapy with coenzyme Q10

Speaker: Professor G. KUKHARCHIK (Kotka, FI)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 1 - Drug therapy, other

Speakers: Doctor C. Di Nora, Professor I. Pershukov, Doctor A. Godinho, Professor G. Rosano, Professor G. KUKHARCHIK
Access
Like
Thumbnail

About the event

Image

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources